Ad is loading...
BUDZ
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
CASBF
Price
$3.90
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
Ad is loading...

BUDZ vs CASBF

Header iconBUDZ vs CASBF Comparison
Open Charts BUDZ vs CASBFBanner chart's image
WEED
Price$0.04
Change-$0.00 (-0.00%)
Volume$202.52K
CapitalizationN/A
CANSINO BIOLOGICS
Price$3.90
Change-$0.00 (-0.00%)
Volume$1.05K
CapitalizationN/A
BUDZ vs CASBF Comparison Chart
Loading...
BUDZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BUDZ vs. CASBF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUDZ is a Hold and CASBF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BUDZ: $0.04 vs. CASBF: $3.90)
Brand notoriety: BUDZ and CASBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BUDZ: 354% vs. CASBF: 145%
Market capitalization -- BUDZ: $10.93M vs. CASBF: $1.92B
BUDZ [@Pharmaceuticals: Other] is valued at $10.93M. CASBF’s [@Pharmaceuticals: Other] market capitalization is $1.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BUDZ’s FA Score shows that 0 FA rating(s) are green whileCASBF’s FA Score has 1 green FA rating(s).

  • BUDZ’s FA Score: 0 green, 5 red.
  • CASBF’s FA Score: 1 green, 4 red.
According to our system of comparison, CASBF is a better buy in the long-term than BUDZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BUDZ’s TA Score shows that 4 TA indicator(s) are bullish.

  • BUDZ’s TA Score: 4 bullish, 3 bearish.

Price Growth

BUDZ (@Pharmaceuticals: Other) experienced а +9.39% price change this week, while CASBF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

BUDZ is expected to report earnings on Mar 31, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CASBF($1.92B) has a higher market cap than BUDZ($10.9M). CASBF YTD gains are higher at: 32.114 vs. BUDZ (-50.548). CASBF has higher annual earnings (EBITDA): 1.09B vs. BUDZ (-949.49K). CASBF has more cash in the bank: 7.01B vs. BUDZ (95.8K). BUDZ has less debt than CASBF: BUDZ (721K) vs CASBF (2.14B). CASBF has higher revenues than BUDZ: CASBF (2.87B) vs BUDZ (0).
BUDZCASBFBUDZ / CASBF
Capitalization10.9M1.92B1%
EBITDA-949.49K1.09B-0%
Gain YTD-50.54832.114-157%
P/E RatioN/A9.30-
Revenue02.87B-
Total Cash95.8K7.01B0%
Total Debt721K2.14B0%
FUNDAMENTALS RATINGS
BUDZ: Fundamental Ratings
BUDZ
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BUDZ
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BUDZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNAX22.46-0.15
-0.66%
MFS Equity Income A
CSMDX16.52-0.16
-0.96%
Copeland SMID Cap Dividend Growth I
SPFFX27.01-0.39
-1.42%
Sphere 500 Climate Fund
LGLQX43.97-0.76
-1.70%
Lord Abbett Growth Leaders R2
HCMZX21.72-0.45
-2.03%
HCM Dividend Sector Plus R

BUDZ and

Correlation & Price change

A.I.dvisor tells us that BUDZ and CBWTF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BUDZ and CBWTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BUDZ
1D Price
Change %
BUDZ100%
-8.42%
CBWTF - BUDZ
14%
Poorly correlated
-5.26%
BMMJ - BUDZ
11%
Poorly correlated
-24.07%
BOIRF - BUDZ
7%
Poorly correlated
N/A
CANN - BUDZ
7%
Poorly correlated
-6.99%
BIOYF - BUDZ
6%
Poorly correlated
N/A
More

CASBF and

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
-0.71%
CNTMF - CASBF
2%
Poorly correlated
+3.64%
BUDZ - CASBF
2%
Poorly correlated
-8.42%
CBWTF - CASBF
1%
Poorly correlated
-5.26%
CPHRF - CASBF
0%
Poorly correlated
-0.51%
More